{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:07:05Z","timestamp":1777014425962,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T00:00:00Z","timestamp":1443398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10719-015-9620-8","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T05:36:16Z","timestamp":1443418576000},"page":"695-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Interactions between nattokinase and heparin\/GAGs"],"prefix":"10.1007","volume":"32","author":[{"given":"Fuming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Linhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"key":"9620_CR1","doi-asserted-by":"crossref","unstructured":"Takaoka, S., Ogasawara, K., Moriyama, H: Production of Nattokinase as a Fibrinolytic Enzyme by an Ingenious\u00a0Fermentation Technology: Safety and Efficacy Studies. In: Bagchi, D., Lau, F.C., Ghos, D.K. (eds.) Biotechnology in Functional Foods and Nutraceuticals, pp. 332\u2013360. CRC, Boca Raton (2010)","DOI":"10.1201\/9781420087123-c19"},{"key":"9620_CR2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/BF01956052","volume":"43","author":"H Sumi","year":"1987","unstructured":"Sumi, H., Hamada, H., Tsushima, H., Mihara, H., Muraki, H.: A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; atypical and popular soybean food in the Japanese diet. Experientia 43, 1110\u20131111 (1987)","journal-title":"Experientia"},{"key":"9620_CR3","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1007\/s00253-014-6135-3","volume":"98","author":"F Dabbagh","year":"2014","unstructured":"Dabbagh, F., Negahdaripour, M., Berenjian, A., Behfar, A., Mohammadi, F., Zamani, M., Irajie, C., Ghasemi, Y.: Nattokinase: production and application. Appl. Microbiol. Biotechnol. 98, 9199\u20139206 (2014)","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"9620_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000205051","volume":"84","author":"H Sumi","year":"1990","unstructured":"Sumi, H., Hamada, H., Nakanishi, K., Hiratani, H.: Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol. 84, 139\u2013143 (1990)","journal-title":"Acta Haematol."},{"key":"9620_CR5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1006\/bbrc.1993.2624","volume":"197","author":"M Fujita","year":"1993","unstructured":"Fujita, M., Nomura, K., Hong, K., Ito, Y., Asada, A., Nishimuro, S.: Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem. Biophys. Res. Commun. 197, 1340\u20131347 (1993)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9620_CR6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1248\/bpb.18.1194","volume":"18","author":"M Fujita","year":"1995","unstructured":"Fujita, M., Hong, K., Ito, Y., Misawa, S., Takeuchi, N., Kariya, K., Nishimuro, S.: Transport of nattokinase across the rat intestinal tract. Biol. Pharm. Bull. 18, 1194\u20131196 (1995)","journal-title":"Biol. Pharm. Bull."},{"key":"9620_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nutres.2009.01.009","volume":"29","author":"CH Hsia","year":"2009","unstructured":"Hsia, C.H., Shen, M.C., Lin, J.S., Wen, Y.K., Hwang, K.L., Cham, T.M., Yang, N.C.: Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr. Res. 29, 190\u2013196 (2009)","journal-title":"Nutr. Res."},{"key":"9620_CR8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1291\/hypres.31.1583","volume":"31","author":"JY Kim","year":"2008","unstructured":"Kim, J.Y., Gum, S.N., Paik, J.K., Lim, H.H., Kim, K.C., Ogasawara, K., Inoue, K., Park, S., Jang, Y., Lee, J.H.: Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertens. Res. 31, 1583\u20131588 (2008)","journal-title":"Hypertens. Res."},{"key":"9620_CR9","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1248\/bpb.34.1696","volume":"34","author":"M Fujita","year":"2011","unstructured":"Fujita, M., Ohnishi, K., Takaoka, S., Ogasawara, K., Fukuyama, R., Nakamuta, H.: Antihypertensive effects of continuous oral administration of nattokinase and its fragments in spontaneously hypertensive rats. Biol. Pharm. Bull. 34, 1696\u20131701 (2011)","journal-title":"Biol. Pharm. Bull."},{"key":"9620_CR10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0960327112467040","volume":"32","author":"NN Fadl","year":"2013","unstructured":"Fadl, N.N., Ahmed, H.H., Booles, H.F., Sayed, A.H.: Serrapeptase and nattokinase intervention for relieving Alzheimer\u2019s disease pathophysiology in rat model. Hum. Exp. Toxicol. 32, 721\u2013735 (2013)","journal-title":"Hum. Exp. Toxicol."},{"key":"9620_CR11","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1167\/iovs.05-0130","volume":"47","author":"A Takano","year":"2006","unstructured":"Takano, A., Hirata, A., Ogasawara, K., Sagara, N., Inomata, Y., Kawaji, T., Tanihara, H.: Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis. Invest. Ophthalmol. Vis. Sci. 47, 2075\u20132079 (2006)","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9620_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","volume":"41","author":"I Capila","year":"2002","unstructured":"Capila, I., Linhardt, R.J.: Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 41, 391\u2013412 (2002)","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"9620_CR13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","volume":"71","author":"JD Esko","year":"2002","unstructured":"Esko, J.D., Selleck, S.B.: Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435\u2013471 (2002)","journal-title":"Annu. Rev. Biochem."},{"key":"9620_CR14","doi-asserted-by":"crossref","first-page":"17R","DOI":"10.1093\/glycob\/cwh051","volume":"14","author":"AK Powell","year":"2004","unstructured":"Powell, A.K., Yates, E.A., Fernig, D.G., Turnbull, J.E.: Interactions of heparin\/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology 14, 17R\u201330R (2004)","journal-title":"Glycobiology"},{"key":"9620_CR15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1126\/science.271.5252.1116","volume":"271","author":"S Faham","year":"1996","unstructured":"Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., Rees, D.C.: Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116\u20131120 (1996)","journal-title":"Science"},{"key":"9620_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-6215(96)90611-4","volume":"294","author":"EA Yates","year":"1996","unstructured":"Yates, E.A., Santini, F., Guerrini, M., Naggi, A., Torri, G., Casu, B.: 1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydr. Res. 294, 15\u201327 (1996)","journal-title":"Carbohydr. Res."},{"key":"9620_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI0214996","volume":"110","author":"L Wang","year":"2002","unstructured":"Wang, L., Brown, J.R., Varki, A., Esko, J.D.: Heparin\u2019s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J. Clin. Invest. 110, 127\u2013136 (2002)","journal-title":"J. Clin. Invest."},{"key":"9620_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bbrc.2000.3453","volume":"276","author":"M Hernaiz","year":"2000","unstructured":"Hernaiz, M., Liu, J., Rosenberg, R.D., Linhardt, R.J.: Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III. Biochem. Biophys. Res. Commun. 276, 292\u2013297 (2000)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9620_CR19","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1021\/bi052403n","volume":"45","author":"E Munoz","year":"2006","unstructured":"Munoz, E., Xu, D., Kemp, M., Zhang, F., Liu, J., Linhardt, R.J.: Affinity, kinetic, and structural study of the interaction of 3-O-sulfotransferase isoform 1 with heparan sulfate. Biochemistry 45, 5122\u20135128 (2006)","journal-title":"Biochemistry"},{"key":"9620_CR20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biochi.2011.10.015","volume":"94","author":"F Zhang","year":"2013","unstructured":"Zhang, F., Liang, X., Pu, D., George, K.I., Holland, P.J., Walsh, S.T., Linhardt, R.J.: Biophysical characterization of glycosaminoglycan-IL-7 interactions using SPR. Biochimie 94, 242\u2013249 (2013)","journal-title":"Biochimie"},{"key":"9620_CR21","first-page":"45","volume":"2","author":"RJ Linhardt","year":"1991","unstructured":"Linhardt, R.J.: Heparin: an important drug enters its seventh decade. Chem. Ind. 2, 45\u201350 (1991)","journal-title":"Chem. Ind."},{"key":"9620_CR22","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1073\/pnas.77.11.6551","volume":"77","author":"U Lindahl","year":"1980","unstructured":"Lindahl, U., Backstrom, G., Thunberg, L., Leder, I.G.: Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc. Natl. Acad. Sci. U. S. A. 77, 6551\u20136555 (1980)","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"9620_CR23","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1021\/bi00344a063","volume":"24","author":"DH Atha","year":"1985","unstructured":"Atha, D.H., Lormeau, J.C., Petitou, M., Rosenberg, R.D., Choay, J.: Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 24, 6723\u20136729 (1985)","journal-title":"Biochemistry"},{"key":"9620_CR24","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1016\/S0021-9258(19)43472-8","volume":"248","author":"RD Rosenberg","year":"1973","unstructured":"Rosenberg, R.D., Damus, P.S.: The purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 248, 6490\u20136505 (1973)","journal-title":"J. Biol. Chem."},{"key":"9620_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","volume":"1492","author":"T Nishimura","year":"2000","unstructured":"Nishimura, T., Nakatake, Y., Konishi, M., Itoh, N.: Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 1492, 203\u2013206 (2000)","journal-title":"Biochim. Biophys. Acta"},{"key":"9620_CR26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","volume":"22","author":"DM Ornitz","year":"2000","unstructured":"Ornitz, D.M.: FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 22, 108\u2013112 (2000)","journal-title":"Bioessays"},{"key":"9620_CR27","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/bi00179a006","volume":"33","author":"LD Thompson","year":"1994","unstructured":"Thompson, L.D., Pantoliano, M.W., Springer, B.A.: Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry 33, 3831\u20133840 (1994)","journal-title":"Biochemistry"},{"key":"9620_CR28","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1021\/bi00071a026","volume":"32","author":"H Mach","year":"1993","unstructured":"Mach, H., Volkin, D.B., Burke, C.J., Middaugh, C.R., Linhardt, R.J., Fromm, J.R., Loganathan, D., Mattsson, L.: Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry 32, 5480\u20135489 (1993)","journal-title":"Biochemistry"},{"key":"9620_CR29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8456318","volume":"259","author":"M Kan","year":"1993","unstructured":"Kan, M., Wang, F., Xu, J., Crabb, J.W., Hou, J., McKeehan, W.L.: An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259, 1918\u20131921 (1993)","journal-title":"Science"},{"key":"9620_CR30","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1021\/bi991895z","volume":"39","author":"M Fannon","year":"2000","unstructured":"Fannon, M., Forsten, K.E., Nugent, M.A.: Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry 39, 1434\u20131445 (2000)","journal-title":"Biochemistry"}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-015-9620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10719-015-9620-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-015-9620-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T10:25:25Z","timestamp":1653215125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10719-015-9620-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9620"],"URL":"https:\/\/doi.org\/10.1007\/s10719-015-9620-8","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]}}}